Pendulum Therapeutics is a biotechnology company that develops microbiome-based therapies for metabolic and inflammatory diseases. The company's lead product, Pendulum Glucose Control, is a probiotic supplement that helps manage blood sugar levels in people with type 2 diabetes. Pendulum's products are based on research into the role of the microbiome in human health, and the company is focused on developing therapies that can restore balance to the microbiome and improve health outcomes. Pendulum Therapeutics was founded in 2012 and is headquartered in Brisbane, California.